Development and Preliminary Evaluation of a Leukocyte Removal Aptamer Filter.
- Author:
Yangwon LEE
1
;
Eun Suk JUNG
;
Kyoung Young CHOI
;
Myung Han KIM
;
So Yong KWON
;
Nam Sun CHO
;
Jin Sook KIM
;
Han Jeong PARK
;
Byoung Don HAN
;
Soo Young YOON
Author Information
1. Korea University School of Medicine, Korea University College of Medicine, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
Aptamer;
CD45;
Leukocyte reduction
- MeSH:
Blood Group Incompatibility;
Filtration;
Leukocytes;
Magnetic Fields;
Red Cross
- From:Korean Journal of Blood Transfusion
2012;23(2):107-114
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Leukocyte reduction filters are widely used to prevent transfusion reactions caused by leukocytes in blood components. Commercial filters are not sufficient for removal of leukocytes for prevention of transfusion associated graft-versus-host disease; therefore, irradiation of blood components was performed using expensive equipment. Techniques using an aptamer substituted for antibody have been developed and are available in clinical areas. The purpose of this study is to develop the aptamer filter system and to evaluate its efficiency and the possibility of its clinical application. METHODS: Aptamers targeted to CD45 were selected by the Postech Aptamer Initiative. The aptamer filter in which aptamers attached to beads were bound to leukocytes and removed by magnetic field was developed. Filtration of 14 units of leukoreduction-red blood provided by Korean Red Cross Blood Services was performed using aptamer filters. Leukocyte removal rate and red cell recovery rate were evaluated and bacterial culture was performed. RESULTS: After filtration using the aptamer filters, 45.6% of leukocytes were additionally removed and the red cell recovery rate was 92.8%. No growth in the bacterial culture was observed. CONCLUSION: In order to apply the cell depletion technique utilizing an aptamer to blood filter system, we developed and evaluated the aptamer filter system. Through improvement of the binding efficiency of the aptamer and the filtering process, and application of the various aptamers for other different cells, we suggest that this technique can be applied in the clinical area, such as a substitution for the irradiation process for TAGVHD prevention.
